Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Inter Parfums Shares Face Pressure as Analysts Adjust Outlook

Robert Sasse by Robert Sasse
September 11, 2025
in Analysis, Consumer & Luxury, Earnings
0
Inter Parfums Stock
0
SHARES
157
VIEWS
Share on FacebookShare on Twitter

Fragrance and cosmetics company Inter Parfums finds itself navigating turbulent market conditions following a series of analyst downgrades and disappointing quarterly results. The stock has entered a discernible downward trajectory, marked by notable price declines and revised projections from financial institutions.

Market Experts Apply the Brakes

Equity research firm Oddo BHF recently adjusted its position on Inter Parfums, reducing its price target from €38 to €34. While the firm maintained its “Neutral” rating on the stock, this revision contributed to an immediate 3.8% drop in the share price. This analyst action was precipitated by interim financial results indicating a softening in business volumes. Since the start of the year, the stock has declined by 13.5%.

A more optimistic counterpoint comes from Berenberg, which reaffirmed its “Buy” recommendation with a €43 price objective. Their analysts acknowledged headwinds for the second half of the year, citing increased tariff expenses and a less favorable US dollar exchange rate. However, they emphasized the company’s underlying strengths, including a powerful brand portfolio, minimal debt levels, and a consistent management team.

Second Quarter Performance Falls Short of Forecasts

The company’s financial results for the second quarter of its 2025 fiscal year failed to meet market expectations. Earnings per share (EPS) came in at $0.99, significantly below the consensus forecast of $1.21. Revenue also missed the mark, reaching $334 million against projections of $357.56 million. This earnings announcement triggered a further 2.07% decrease in the stock’s value.

Should investors sell immediately? Or is it worth buying Inter Parfums?

Despite these setbacks, several positive indicators emerged from the report:
* The gross margin expanded by 170 basis points to a healthy 66.2%
* Year-to-date operating income saw a modest 1% increase
* Net sales for the first six months climbed 1% to $673 million

A regional breakdown reveals a mixed performance. European sales grew by 6% in the quarter, fueled by robust demand for key brands such as Lacoste (+59%) and Coach (+42%). In stark contrast, sales in the US market contracted by 20%, a drop primarily attributed to the termination of the Dunhill fragrance license.

Maintaining Guidance with a Focus on Holiday Sales

In spite of recent challenges, Inter Parfums’ leadership has reaffirmed its full-year guidance for 2025, projecting revenue of $1.51 billion and EPS of $5.35. The company’s strategy hinges on leveraging its established brands, launching new product innovations, and capitalizing on the critical year-end holiday shopping season. A major initiative includes the launch of its new proprietary brand, Solférino, which will feature a line of ten niche fragrances.

Governance Changes with Board Expansion

During a recent shareholder meeting, investors approved a proposal to increase the size of the company’s supervisory board from nine to eleven members. This expansion welcomes two new appointees: Patrick Bousquet-Chavanne, who brings 35 years of consumer goods expertise, and Hervé Bouillonnec, the Chief Commercial Officer of Interparfums USA.

Ad

Inter Parfums Stock: Buy or Sell?! New Inter Parfums Analysis from February 7 delivers the answer:

The latest Inter Parfums figures speak for themselves: Urgent action needed for Inter Parfums investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Inter Parfums: Buy or sell? Read more here...

Tags: Inter Parfums
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Next Post
Overstock Stock

Rebranding Raises Questions About Bed Bath & Beyond's Future Direction

Daqo New Energy Stock

Analyst Confidence Soars for Daqo New Energy Despite Quarterly Loss

Certara Stock

Can Certara's Market Leadership in Biosimulation Spark a Stock Revival?

Recommended

Eli Lilly Stock

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

3 months ago
Applovin Stock

Regulatory Storm Clouds Gather Over Applovin

4 months ago
Apple Stock

Berkshire’s Apple Share Sale Sparks Market Speculation Ahead of Key Launch

5 months ago
Asml Stock

Is ASML Stock Presenting a Major Buying Opportunity?

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Trending

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

by Jackson Burston
February 7, 2026
0

In late January 2026, ServiceNow reported quarterly financial results that surpassed even the most optimistic projections from...

Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com